Document Detail


Impaired carbon monoxide diffusing capacity as a marker of limited systemic sclerosis.
MedLine Citation:
PMID:  22075318     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: As impairment of diffusing capacity for carbon monoxide (DLCO) likely reflects underlying pulmonary vasculopathy in limited systemic sclerosis (lSSc), we examined whether DLCO could help to distinguish secondary from idiopathic Raynaud's phenomenon (iRP).
METHODS: We compared pulmonary function test (PFT) results in 145 lSSc patients and 24 age- and sex-matched iRP patients. RP duration at time of PFT was similar in the two groups.
RESULTS: DLCO values were low (<80% of predicted) in 106 (73%) of the 145 lSSc patients, and in 69 (71%) of the 97 patients with early lSSc. Interstitial lung disease (ILD) was found in 10% of lSSc patients. DLCO was significantly lower in lSSc than in iRP (72±15% versus 89±9%, p<0.0001). When evaluated, alveolar capillary membrane conductance (Dm) was markedly lower in lSSc patients without ILD than in iRP patients (45±12% versus 71±2.5%, p=0.003), although capillary blood volume was not different. DLCO was low in 3 iRP patients (12.5%). The sensitivity and specificity of low DLCO values for early lSSc diagnosis in patients with Raynaud's phenomenon were 71% and 87.5%, respectively. Sensitivity was similar to that of anti-centromere-antibodies (75%) and nailfold capillary abnormalities (81%). A DLCO cutoff of <70% had a sensitivity and specificity of 41% and 100%, respectively. In multivariable analysis, age and low DLCO were the only independent predictors of death; the hazard ratio for DLCO ≤50% was 7.9 (95% CI 2.3-26, p=0.0007).
CONCLUSION: Isolated DLCO impairment is significantly more frequent in patients with lSSc than in patients with idiopathic iRP. DLCO measurement could be a useful diagnostic tool for lSSc.
Authors:
Salim Trad; Du Le Thi Huong; Camille Frances; Bertrand Wechsler; Patrice Cacoub; Nathalie Costedoat; Julien Haroche; Jean-Charles Piette; Thomas Hanslik; Zahir Amoura
Related Documents :
22085408 - Soluble urokinase-type plasminogen activator receptor levels in patients with burn inju...
11720318 - Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to...
17012968 - Clinical guidelines for the medical management of left-sided ulcerative colitis and ulc...
1613298 - Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopatholog...
17452128 - Cardiovascular manifestations in fabry disease: a clinical and echocardiographic study.
2784008 - Effect of spinal cord stimulation on motor performances in hemiplegics.
Publication Detail:
Type:  Journal Article     Date:  2011-06-12
Journal Detail:
Title:  European journal of internal medicine     Volume:  22     ISSN:  1879-0828     ISO Abbreviation:  Eur. J. Intern. Med.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9003220     Medline TA:  Eur J Intern Med     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  e80-6     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Affiliation:
Service de Médecine Interne, CHU Ambroise Paré, 9 av Charles de Gaulle 92100 Boulogne, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Monosensitization and polysensitization in allergic rhinitis.
Next Document:  Removal of retrievable vena cava filters in routine practice: A multicenter study.